The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EORTC CLTF 2021 | Key updates from EORTC CL 2021
Jan P. Nicolay, MD, Ruprecht Karls University of Heidelberg, Mannheim, Germany, gives an overview of key updates presented at the EORT CLTF 2021 meeting, highlighting data from the Prospective Cutaneous Lymphoma International Prognostic Indices (PROCLIPI) study, and the identification of novel relevant pathways in cutaneous T-cell lymphoma (CTCL) and cutaneous B-cell lymphoma (CBCL). This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.
